The patient flow approach was tested with the Clinical Reference Group, Finance and Analytics Group, and Start Well Programme Board. The outputs were also tested with the Strategy Leads from each organisation, and the approach reviewed and assured by the London Clinical Senate and NHS England.
]]>The NICE has published guidance that recommends the antivirals Paxlovid, Veklury, and Lagevrio for the treatment of COVID-19, both in the community, and for patients in hospital. This guidance sets out the eligibility criteria and ensures that patients who are at the highest risk of developing severe disease from COVID-19 have access to clinically and cost-effective treatments. Patients with long COVID have not been identified as a distinct group that would be eligible for treatment, and there are currently no licensed antivirals for the treatment of long COVID. The NICE therefore has no current plans to review the eligibility criteria in its guidance. The NICE maintains surveillance of new evidence that may affect its published guidance, and would consult on proposed changes if significant new evidence were to emerge.
]]>- EnABLE, a disability and long-term conditions network;
- Autism Network;
- Attention Deficit Hyperactivity Disorder Network;
- Dyslexia and Dyspraxia Network;
- Race Equality Matters Network;
- Prism, an LGBT+ network;
- Women’s Network;
- Parents’ Network;
- Age Diversity Network;
- Carers’ Network;
- Care Leavers’ Network;
- Social Mobility Network;
- Men’s Health Network;
- Christian Network;
- Jewish Network;
- Muslim Network;
- Hinduism and Sikhism Group;
- Humanists Network;
- Diversity and Inclusion Analytical Network;
- Domestic Abuse Support Group;
- Working Through Cancer Network; and
- Mental Health First Aid.
The following networks support and promote professional development and operational delivery:
- International Network;
- Flexible Working Network;
- Green Network;
- Social Workers Network;
- Health Science and Engineering Network;
- IT User Engagement Group;
- Clinicians’ Network;
- Nutritionist Network;
- Perspectives Network;
- History Network;
- Culture and Engagement Champions Network;
- Active Travel Network;
- International Network;
- First Aid Network;
- Administrative Officer and Executive Officer Network;
- Personal Assistant Network;
- Senior Executive Officer and Higher Executive Officer Network;
- G6 and G7 Network; and
- Direct Appointment Scheme Network.
]]>- in 2018/19, there were 176 admissions to National Health Service hospitals in England where polio was recorded as the diagnosis, and 797 admissions where post-polio syndrome was recorded as the diagnosis;
- in 2019/20, there were 187 admissions to NHS hospitals in England where polio was recorded as the diagnosis, and 813 admissions where post-polio syndrome was recorded as the diagnosis;
- in 2020/21, there were 107 admissions to NHS hospitals in England where polio was recorded as the diagnosis, and 522 admissions where post-polio syndrome was recorded as the diagnosis;
- in 2021/22, there were 115 admissions to NHS hospitals in England where polio was recorded as the diagnosis, and 630 admissions where post-polio syndrome was recorded as the diagnosis; and
- in 2022/23, there were 104 admissions to NHS hospitals in England where polio was recorded as the diagnosis, and 632 admissions where post-polio syndrome was recorded as the diagnosis.
It is important to note that the number of admissions does not represent the number of patients, as a person may have more than one admission within the period. It is estimated that there are approximately 120,000 people living in the United Kingdom who survived polio when they were younger. Some of these have, or will develop, post-polio syndrome.
]]>45 organisations who participated in the NHS England pilot, broken down into 42 trusts, two integrated care boards, and the City Healthcare Partnership Community Interest Company, have begun to transition into the Federated Data Platform, in a sequence of waves scheduled between March and May 2024. NHS England aims for all trusts and integrated care boards who wish to use the platform to do so within the next three years.
]]>The cross-Government bereavement group enables Government departments to share the best practice about bereavement support in the sectors for which they are responsible. The UKCB Steering Group has presented to the cross-Government working group on several occasions, and last attended a meeting of the group in September 2023.
]]>The Be Part of Research campaign makes it easier for people to find out about, and take part in, health and care research. Currently, there are seven high quality studies related to heart and circulation, which are being supported by the NIHR and are within five miles of Romford.
The NHS Long Term Plan sets out that by 2028 the proportion of patients accessing cardiac rehabilitation will be amongst the best in Europe, with up to 85% of those eligible accessing care. This will prevent up to 23,000 premature deaths and 50,000 acute admissions over 10 years. The NHS Health Check programme is a core component of England's cardiovascular diseases prevention pathway. Over 15 million people are eligible for an NHS Health Check every five years, and it delivers 1.3 million checks a year, preventing an estimated 500 heart attacks and strokes.
]]>To reduce waiting times for elective surgeries specifically, we are transforming the way the NHS provides elective surgeries, by increasing activity through dedicated and protected surgical hubs. £1.5 billion of funding has been awarded for the development of new surgical hubs and the expansion of surgical hub sites, as well as increased bed capacity and equipment, to help elective services recover. The hubs will focus on providing high volume low complexity surgery, as recommended by the Royal College of Surgeons of England. There are currently 100 elective surgical hubs that are operational across England, as of March 2024. These surgical hubs help to separate elective care facilities from urgent and emergency care.
]]>NHS Blood and Transplant (NHSBT) is the largest provider of apheresis services, a blood transfusion used to treat SCD. NHSBT will be delivering projects over the next 12 months that will increase both nursing capacity and the physical space in which apheresis occurs. We are also working to increase Ro subtype blood donation numbers, the blood type used to treat SCD, identify opportunities to improve clinical pathways, and deliver world-leading treatments, such as the new blood matching genetic test announced by NHS England earlier this year, which will reduce the risk of side effects and offer more personalised care.
NHS England’s Chief Executive Officer has committed to improving the treatment and outcomes of patients with SCD, and has commissioned a Sickle Cell Pathway Quality Improvement work package. A quality improvement review of existing processes has led to a range of improvements including awareness, education, and training of both patients and professionals.
The National Healthcare Inequalities Improvement Programme (HiQiP) has recently introduced a number of initiatives as part of the wider aim of tackling inequalities for people living with SCD. This includes: piloting of urgent and emergency department bypass units in London and Manchester, which will ensure people with SCD with an uncomplicated vaso-occlusive crisis are assessed and given pain relief in a timely manner; the provision of a credit card sized Sickle Cell Alert Card to all people with SCD, to alert medical and clinical staff that the carrier is a registered SCD patient and that they should be managed as a medical emergency; a London wide commissioning for the design and upload of a patient care record onto an interoperable digital platform which, when fully operational, will give clinicians and medical personnel in different regions access to a patient’s personalised care and analgesia record, removing ambiguity on effective treatment; and several products to support the above, including a communications campaign to raise awareness of existing NHS England arrangements to support people with SCD to save money on the costs of regular prescriptions, as well as the Can you tell it's Sickle Cell campaign and an e-learning module, both from NHS England. Further information on the Can you tell it's Sickle Cell campaign and the e-learning module is available respectively, at the following links:
https://www.england.nhs.uk/2022/06/nhs-launches-lifesaving-sickle-cell-campaign/
]]>Each organisation’s terms and conditions of employment include strict guidelines on how staff handle and protect patients’ information. Staff must also be regularly trained in information governance responsibilities. Professional bodies such as the General Medical Council also set out standards which their members must meet.
General practices have two options if they are worried that having access to their record might cause harm to a patient or another individual. They can either redact specific items on the record, or disable patient access entirely.
]]>The National Institute for Health and Care Excellence has produced a clinical knowledge summary, last revised in November 2023, which outlines the method healthcare professionals should follow for diagnosing PoTS. This summary is available at the following link:
https://cks.nice.org.uk/topics/blackouts-syncope/diagnosis/assessment/
Clinical knowledge summaries are evidence-based summaries designed to support healthcare professionals in primary care, by providing them with a readily accessible summary of the current evidence base and practical advice on best practice.
]]>We expect integrated care boards (ICBs) and National Health Service trusts to have due regard to relevant NICE guidelines. It is the responsibility of ICBs to make available the appropriate provision to meet the health and care needs of their local population, in line with these NICE guidelines.
More generally, cutting waiting lists is one of the Prime Minister’s top priorities. We are making good progress on tackling the longest waits, to ensure patients get the care they need when they need it. Ambitions to eliminate long waits were set out in the elective recovery plan, with the overall aim of eliminating waits of over a year for elective care, by March 2025.
To facilitate this across elective services, we are increasing activity, with plans to spend more than £8 billion from 2022/23 to 2024/25. This includes expanding capacity through the creation of a new network of community diagnostic centres, and maximising all available independent sector capacity.
]]>
| 2019/20 | 2020/21 | 2021/22 | 2022/23 |
NHS Darlington Clinical Commissioning Group (CCG) | £177,000,000 | 0 | 0 | 0 |
NHS Tees Valley CCG | 0 | £1,293,000,000 | £1,502,000,000 | £341,000,000 |
NHS North East and North Cumbria Integrated Care Board (ICB) | 0 | 0 | 0 | £5,171,000,000 |
The number and commissioning responsibilities of the CCGs, now ICBs, have changed during the period requested, and expenditure levels set out in the table are not directly comparable year-on-year. On 1 July 2022, the NHS North East and North Cumbria ICB replaced and took on responsibility for eight CCGs, including Tees Valley, which is reflected in the higher level of spend in 2022/23.
North Central London Integrated Care Board expect it will take some months to develop the decision-making business case. The meeting will be held in public, with further details published later this year.
]]>